Literature DB >> 12700085

T lymphocyte responses are critical determinants in the pathogenesis and resistance to mycoplasma respiratory disease.

Harlan P Jones1, Jerry W Simecka.   

Abstract

Mycoplasmas are responsible for many human and animal respiratory diseases and have a tremendous economic and health impact worldwide. Currently, there is no vaccine against any animal or human mycoplasma species. Despite the vast amount of research, the mechanisms that control hosts' resistance and susceptibility to mycoplasma infection remains unclear. Immune responses, particularly T lymphocyte responses, are believed to be critical players in the pathogenesis of mycoplasma disease. In this review, we will highlight the potential roles of T lymphocytes as influential mediators in animal and human mycoplasma pathogenesis and resistance infection.

Entities:  

Mesh:

Year:  2003        PMID: 12700085     DOI: 10.2741/1098

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  11 in total

1.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.

Authors:  Maximillion T Mize; Xiangle L Sun; Jerry W Simecka
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

3.  Rat strains differ in susceptibility to Ureaplasma parvum-induced urinary tract infection and struvite stone formation.

Authors:  Leticia Reyes; Mary Reinhard; L J O'donell; Janet Stevens; Mary B Brown
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

4.  Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma.

Authors:  Wees Love; Nicole Dobbs; Leslie Tabor; Jerry W Simecka
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

5.  Antigen-pulsed bone marrow-derived and pulmonary dendritic cells promote Th2 cell responses and immunopathology in lungs during the pathogenesis of murine Mycoplasma pneumonia.

Authors:  Nicole A Dobbs; Xia Zhou; Mark Pulse; Lisa M Hodge; Trenton R Schoeb; Jerry W Simecka
Journal:  J Immunol       Date:  2014-06-27       Impact factor: 5.422

Review 6.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

7.  Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses.

Authors:  Adam N Odeh; Jerry W Simecka
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

8.  Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins.

Authors:  Anneleen M F Matthijs; Gaël Auray; Virginie Jakob; Obdulio García-Nicolás; Roman O Braun; Irene Keller; Rémy Bruggman; Bert Devriendt; Filip Boyen; Carlos A Guzman; Annelies Michiels; Freddy Haesebrouck; Nicolas Collin; Christophe Barnier-Quer; Dominiek Maes; Artur Summerfield
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

9.  Dendritic cells are the major antigen presenting cells in inflammatory lesions of murine Mycoplasma respiratory disease.

Authors:  Xiangle Sun; Harlan P Jones; Nicole Dobbs; Sheetal Bodhankar; Jerry W Simecka
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

10.  Transcriptome Analysis of Bronchoalveolar Lavage Fluid From Children With Mycoplasma pneumoniae Pneumonia Reveals Natural Killer and T Cell-Proliferation Responses.

Authors:  Man Gao; Kuo Wang; Mingyue Yang; Fanzheng Meng; Ruihua Lu; Huadong Zhuang; Genhong Cheng; Xiaosong Wang
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.